Barbara Gayle Duncan Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Barbara Gayle Duncan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Barbara Gayle Duncan. Barbara Gayle Duncan is a Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).

Address: C/O INTERCEPT PHARMACEUTICALS, INC. 450 W. 15TH STREET, SUITE 505 NEW YORK 10011 NY

Companies in which Barbara Gayle Duncan is an Insider

INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Barbara Gayle Duncan: Chief Financial Officer
Holdings: 14,808 shares
Current Value: $1,681,745
Latest Transaction: Jul 03 2014
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Barbara Gayle Duncan

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 03 2014ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM0.001,29807,789
Jul 03 2014ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...BuyM0.001,298014,80813.5 K to 14.8 K (+9.61 %)
Jan 17 2014ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM31.905,625179,43816,875
Jan 17 2014ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS283.9025070,97510,70811 K to 10.7 K (-2.28 %)
Jan 17 2014ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS280.0012535,00010,95811.1 K to 11 K (-1.13 %)
Jan 17 2014ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS274.005013,70011,08311.1 K to 11.1 K (-0.45 %)
Jan 17 2014ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS265.0025066,25011,13311.4 K to 11.1 K (-2.20 %)

View all Barbara Gayle Duncan insider transactions.